FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Up

2006P-0299: Determine whether Eloxatin (Oxaliplatin for Injection) 50 mg and 100 mg Sterile Lyophilized Powder Vials (NDA #21-492 has been Withdrawn for Safety or Effectiveness Reasons

Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
 
CP1 07/24/2006 07/24/2006 Private Industry Rothwell, Figg, Ernst & Manbeck, P.C.       pdf  
Signature: Steven Lieberman
ACK1 07/25/2006 07/25/2006 Federal Government FDA/DDM to Rothwell, Figg, Ernst & Manbeck, P.C.       pdf  
Signature: Jennie Butler
EC1 07/28/2006 07/27/2006 Individual Consumer Mr. Dave Lowe       htm
Attachment
 
EC2 08/21/2006 08/19/2006 Individual Consumer Mr. Dave Lowe       htm  

Top | Up

Page last updated August 22, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management